Rubric Capital Management LP Insmed Inc Transaction History

Rubric Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$17.07 - $25.71 $11 Million - $16.6 Million	646,153 Added 100.63%	1,288,276 $25.4 Million
Q1 2022 May 13, 2022	BUY	$20.42 - $28.13 $13.1 Million - $18.1 Million	642,123 New	642,123 $15.1 Million
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $34.6 Million - $44.6 Million	-1,100,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$26.0 - $34.5 $1.77 Million - $2.35 Million	68,000 Added 6.59%	1,100,000 $35.4 Million
Q2 2020 Aug 10, 2020	BUY	$14.11 - $29.42 $4.9 Million - $10.2 Million	347,112 Added 50.68%	1,032,000 $28.4 Million
Q1 2020 May 14, 2020	BUY	$13.63 - $33.98 $9.34 Million - $23.3 Million	684,888 New	684,888 $11 Million

484

182M

2.14M

3.25M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.6B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rubric Capital Management LP with notifications on news.